Matthew Scott Thompson

Title: Matthew Scott Thompson: Innovator in CRISPR Technology

Introduction

Matthew Scott Thompson is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genetic engineering, particularly through his work with CRISPR technology. His innovative approach has led to the development of advanced systems that have the potential to revolutionize genetic research and applications.

Latest Patents

Matthew holds a patent for "Engineered cascade components and cascade complexes." This patent provides engineered Class 1 Type I CRISPR-Cas (Cascade) systems that comprise multi-protein effector complexes, nucleoprotein complexes comprising Type I CRISPR-Cas subunit proteins and nucleic acid guides, polynucleotides encoding Type I CRISPR-Cas subunit proteins, and guide polynucleotides. The patent also discloses methods for making and using these engineered systems, showcasing his innovative contributions to the field.

Career Highlights

Matthew is currently associated with Caribou Biosciences, Inc., where he continues to push the boundaries of genetic engineering. His work has garnered attention for its potential applications in various fields, including medicine and agriculture. With a focus on developing cutting-edge technologies, he is at the forefront of CRISPR research.

Collaborations

Matthew has collaborated with notable professionals in his field, including Peter Sean Cameron and Scott David Gradia. These collaborations have further enhanced his research and development efforts, contributing to the advancement of CRISPR technology.

Conclusion

Matthew Scott Thompson is a key figure in the realm of genetic engineering, with a focus on CRISPR technology. His innovative patent and ongoing work at Caribou Biosciences, Inc. highlight his commitment to advancing scientific knowledge and applications. His contributions are paving the way for future breakthroughs in genetic research.